30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ADMA Biologics Inc (ADMA)

Track

Over the last 90 days, ADMA Biologics Inc. has seen insider activity with a net buy value of $250,874. Notable transactions include multiple buys by Jerrold B. Grossman and Steve Elms, alongside significant planned and proposed sales by Adam S. Grossman and Brad L. Tade. The stock has experienced a 47.5% price decrease in the past 90 days.
Stock chart
Ticker: ADMA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Grossman Jerrold B
1 purchase — total 50,624 USD
Buy 27 May 2026
Value US$1,398,446.56 | Price 498.07 | Shares 82,555
Buy 12 May 2026
Value US$505,223.67 | Price 133.50 | Shares 25,736
Buy 11 May 2026
Value US$100,125.00 | Price 8.01 | Shares 12,500
Planned sale 16 Mar 2026
Value US$90,960.00 | Price 15.16 | Shares 6,000
Planned sale 16 Mar 2026
Value US$227,400.00 | Price 15.16 | Shares 15,000
Proposed sale 10 Mar 2026
Value US$790,911.00 | Price 15.81 | Shares 50,026
Sale 9 Mar 2026
Value US$157,800.48 | Price 15.63 | Shares 10,096
Proposed sale 9 Mar 2026
Value US$155,377.00 | Price 15.39 | Shares 10,096
Buy 6 Mar 2026
Value US$107,730.00 | Price 15.39 | Shares 7,000
Buy 5 Mar 2026
Value US$109,690.00 | Price 15.67 | Shares 7,000
Planned sale 17 Feb 2026
Value US$96,480.00 | Price 16.08 | Shares 6,000
Planned sale 17 Feb 2026
Value US$241,200.00 | Price 16.08 | Shares 15,000
Proposed sale 17 Feb 2026
Value US$2,011,250.00 | Price 16.09 | Shares 125,000
Proposed sale 17 Feb 2026
Value US$1,351,560.00 | Price 16.09 | Shares 84,000
Planned sale 15 Dec 2025
Value US$118,740.00 | Price 19.79 | Shares 6,000
Planned sale 15 Dec 2025
Value US$296,850.00 | Price 19.79 | Shares 15,000
Planned sale 19 Nov 2025
Value US$96,000.00 | Price 16.00 | Shares 6,000
Planned sale 19 Nov 2025
Value US$240,000.00 | Price 16.00 | Shares 15,000
Proposed sale 24 Oct 2025
Value US$960,750.00 | Price 15.25 | Shares 63,000
Planned sale 24 Oct 2025
Value US$96,000.00 | Price 16.00 | Shares 6,000
Planned sale 24 Oct 2025
Value US$240,000.00 | Price 16.00 | Shares 15,000
Planned sale 15 Sep 2025
Value US$96,780.00 | Price 16.13 | Shares 6,000
Planned sale 15 Sep 2025
Value US$241,950.00 | Price 16.13 | Shares 15,000
Planned sale 15 Aug 2025
Value US$101,280.00 | Price 16.88 | Shares 6,000
Planned sale 15 Aug 2025
Value US$253,200.00 | Price 16.88 | Shares 15,000
Planned sale 15 Jul 2025
Value US$111,960.00 | Price 18.66 | Shares 6,000
Planned sale 15 Jul 2025
Value US$279,900.00 | Price 18.66 | Shares 15,000
Proposed sale 15 Jul 2025
Value US$1,176,840.00 | Price 18.68 | Shares 63,000
Planned sale 16 Jun 2025
Value US$124,860.00 | Price 20.81 | Shares 6,000
Planned sale 16 Jun 2025
Value US$312,150.00 | Price 20.81 | Shares 15,000
Sale 16 Jun 2025
Value US$3,941,719.76 | Price 20.24 | Shares 194,749
Sale 13 Jun 2025
Value US$2,871,723.42 | Price 20.82 | Shares 137,931
Sale 12 Jun 2025
Value US$2,015,890.29 | Price 21.69 | Shares 92,941
Proposed sale 12 Jun 2025
Value US$9,308,331.00 | Price 21.87 | Shares 425,621
Sale 9 Jun 2025
Value US$419,200.00 | Price 20.96 | Shares 20,000
Sale 9 Jun 2025
Value US$213,100.00 | Price 21.31 | Shares 10,000
Proposed sale 9 Jun 2025
Value US$206,100.00 | Price 20.61 | Shares 10,000
Proposed sale 4 Jun 2025
Value US$415,000.00 | Price 20.75 | Shares 20,000
Proposed sale 30 May 2025
Value US$388,800.00 | Price 19.44 | Shares 20,000
Sale 22 May 2025
Value US$24,566.52 | Price 20.12 | Shares 1,221
Sale 21 May 2025
Value US$158,069.28 | Price 20.32 | Shares 7,779
Proposed sale 21 May 2025
Value US$183,960.00 | Price 20.44 | Shares 9,000
Planned sale 15 May 2025
Value US$116,700.00 | Price 19.45 | Shares 6,000
Planned sale 15 May 2025
Value US$291,750.00 | Price 19.45 | Shares 15,000
Planned sale 15 Apr 2025
Value US$128,760.00 | Price 21.46 | Shares 6,000
Planned sale 15 Apr 2025
Value US$321,900.00 | Price 21.46 | Shares 15,000
Planned sale 19 Mar 2025
Value US$113,520.00 | Price 18.92 | Shares 6,000
Planned sale 19 Mar 2025
Value US$283,800.00 | Price 18.92 | Shares 15,000
Proposed sale 19 Mar 2025
Value US$1,571,640.00 | Price 18.71 | Shares 84,000
Proposed sale 22 Nov 2024
Value US$1,042,997.10 | Price 21.30 | Shares 48,967
Sale 22 Nov 2024
Value US$1,033,203.70 | Price 21.10 | Shares 48,967
Proposed sale 22 Nov 2024
Value US$319,500.00 | Price 21.30 | Shares 15,000
Sale 22 Nov 2024
Value US$317,250.00 | Price 21.15 | Shares 15,000
Sale 9 Sep 2024
Value US$166,188.60 | Price 18.47 | Shares 9,000
Proposed sale 9 Sep 2024
Value US$146,340.00 | Price 16.26 | Shares 9,000
Proposed sale 30 Aug 2024
Value US$415,863.00 | Price 17.22 | Shares 24,150
Sale 30 Aug 2024
Value US$408,050.48 | Price 16.90 | Shares 24,150
Sale 29 Aug 2024
Value US$2,363,931.62 | Price 17.27 | Shares 136,861
Proposed sale 29 Aug 2024
Value US$2,359,483.64 | Price 17.24 | Shares 136,861
Sale 27 Aug 2024
Value US$6,732,899.69 | Price 17.29 | Shares 389,356
Sale 26 Aug 2024
Value US$4,191,087.57 | Price 17.69 | Shares 236,889
Proposed sale 26 Aug 2024
Value US$11,397,659.00 | Price 18.20 | Shares 626,245
Sale 23 Aug 2024
Value US$1,095,600.00 | Price 18.26 | Shares 60,000
Proposed sale 14 Jun 2024
Value US$5,250,000.00 | Price 10.50 | Shares 500,000
Sale 14 Jun 2024
Value US$1,071,980.00 | Price 10.72 | Shares 100,000
Sale 19 Mar 2024
Value US$2,503,920.32 | Price 6.08 | Shares 411,829
Sale 18 Mar 2024
Value US$299,820.87 | Price 6.01 | Shares 49,887
Sale 15 Mar 2024
Value US$1,099,878.08 | Price 6.01 | Shares 183,008
Sale 14 Mar 2024
Value US$2,712,069.80 | Price 6.05 | Shares 448,276
Sale 13 Mar 2024
Value US$2,527,470.00 | Price 6.21 | Shares 407,000
Proposed sale 13 Mar 2024
Value US$9,330,000.00 | Price 6.22 | Shares 1,500,000
Buy 30 Aug 2023
Value US$482,144.00 | Price 3.71 | Shares 130,000
Buy 24 Aug 2023
Value US$97,500.00 | Price 3.90 | Shares 25,000
Sale 22 Aug 2023
Value US$5,544,736.52 | Price 3.87 | Shares 1,433,304
Proposed sale 22 Aug 2023
Value US$5,544,737.00 | Price 3.87 | Shares 1,433,304
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-27 B Purchase
3.1
Grossman Jerrold B
Non-Executive Director
82,555 +21.9%
498.07
US$1,398,447 		82,555 +21.9% 498.07 US$1,398,447
2026-05-14 2026-05-12 B Purchase
3.1
Grossman Jerrold B
Non-Executive Director
25,736 +3.4%
133.50
US$505,224 		25,736 +3.4% 133.50 US$505,224
2026-05-12 2026-05-11 B Purchase
3.1
Grossman Jerrold B
Non-Executive Director
49,168 -32.6%
11.28
US$182,492 		49,168 -32.6% 11.28 US$182,492
2026-03-17 2026-03-16 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
15.16
US$90,960 		6,000 -0.3% 15.16 US$90,960
2026-03-17 2026-03-16 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
15.16
US$227,400 		15,000 -0.7% 15.16 US$227,400
2026-03-10 2026-03-10 PrS Proposed sale
3.0
Tade Brad L.

Former Officer

Officer
50,026
15.81
US$790,911 		50,026 15.81 US$790,911
2026-03-10 2026-03-09 S Sale
1.7
Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Officer
10,096 -2.1%
15.63
US$157,800 		10,096 -2.1% 15.63 US$157,800
2026-03-09 2026-03-09 PrS Proposed sale
1.7
Kestenberg-Messina Kaitlin M.

Officer

Officer
10,096
15.39
US$155,377 		10,096 15.39 US$155,377
2026-03-09 2026-03-06 B Purchase
2.6
ELMS STEVE
Non-Executive Director
7,000 +0.3%
15.39
US$107,730 		7,000 +0.3% 15.39 US$107,730
2026-03-09 2026-03-05 B Purchase
2.6
ELMS STEVE
Non-Executive Director
7,000 +0.3%
15.67
US$109,690 		7,000 +0.3% 15.67 US$109,690
2026-02-17 2026-02-17 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
16.08
US$96,480 		6,000 -0.3% 16.08 US$96,480
2026-02-17 2026-02-17 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
16.08
US$241,200 		15,000 -0.7% 16.08 US$241,200
2026-02-17 2026-02-17 PrS Proposed sale
3.1
Grossman Adam S.

Director; Officer

Executive Director
125,000
16.09
US$2,011,250 		125,000 16.09 US$2,011,250
2026-02-17 2026-02-17 PrS Proposed sale
3.1
Grossman Adam S.

Director; Officer

Executive Director
84,000
16.09
US$1,351,560 		84,000 16.09 US$1,351,560
2025-12-16 2025-12-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
19.79
US$118,740 		6,000 -0.3% 19.79 US$118,740
2025-12-16 2025-12-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
19.79
US$296,850 		15,000 -0.7% 19.79 US$296,850
2025-11-21 2025-11-19 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
16.00
US$96,000 		6,000 -0.3% 16.00 US$96,000
2025-11-21 2025-11-19 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
16.00
US$240,000 		15,000 -0.7% 16.00 US$240,000
2025-10-24 2025-10-24 PrS Proposed sale
3.1
Grossman Adam S.

Director and Officer

Executive Director
63,000
15.25
US$960,750 		63,000 15.25 US$960,750
2025-10-24 2025-10-24 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
16.00
US$96,000 		6,000 -0.3% 16.00 US$96,000
2025-10-24 2025-10-24 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
16.00
US$240,000 		15,000 -0.7% 16.00 US$240,000
2025-09-16 2025-09-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
16.13
US$96,780 		6,000 -0.3% 16.13 US$96,780
2025-09-16 2025-09-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
16.13
US$241,950 		15,000 -0.7% 16.13 US$241,950
2025-08-15 2025-08-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
16.88
US$101,280 		6,000 -0.3% 16.88 US$101,280
2025-08-15 2025-08-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
16.88
US$253,200 		15,000 -0.7% 16.88 US$253,200
2025-07-16 2025-07-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
18.66
US$111,960 		6,000 -0.3% 18.66 US$111,960
2025-07-16 2025-07-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
18.66
US$279,900 		15,000 -0.7% 18.66 US$279,900
2025-07-15 2025-07-15 PrS Proposed sale
3.1
Grossman Adam S

Director and Officer

Executive Director
63,000
18.68
US$1,176,840 		63,000 18.68 US$1,176,840
2025-06-18 2025-06-16 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
20.81
US$124,860 		6,000 -0.3% 20.81 US$124,860
2025-06-18 2025-06-16 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
20.81
US$312,150 		15,000 -0.7% 20.81 US$312,150
2025-06-16 2025-06-16 S Sale
2.6
ELMS STEVE
Non-Executive Director
194,749 -69.0%
20.24
US$3,941,720 		194,749 -69.0% 20.24 US$3,941,720
2025-06-16 2025-06-13 S Sale
2.6
ELMS STEVE
Non-Executive Director
137,931 -32.8%
20.82
US$2,871,723 		137,931 -32.8% 20.82 US$2,871,723
2025-06-16 2025-06-12 S Sale
2.6
ELMS STEVE
Non-Executive Director
92,941 -4.4%
21.69
US$2,015,890 		92,941 -4.4% 21.69 US$2,015,890
2025-06-12 2025-06-12 PrS Proposed sale
2.6
ELMS STEVE

Director

Non-Executive Director
425,621
21.87
US$9,308,331 		425,621 21.87 US$9,308,331
2025-06-11 2025-06-09 S Sale
3.9
Guiheen Lawrence P.
Non-Executive Director
20,000 -17.4%
20.96
US$419,200 		20,000 -17.4% 20.96 US$419,200
2025-06-10 2025-06-09 S Sale
3.1
Grossman Jerrold B
Non-Executive Director
10,000 -2.0%
21.31
US$213,100 		10,000 -2.0% 21.31 US$213,100
2025-06-09 2025-06-09 PrS Proposed sale
3.1
Grossman Jerrold B

Director

Non-Executive Director
10,000
20.61
US$206,100 		10,000 20.61 US$206,100
2025-06-04 2025-06-04 PrS Proposed sale
3.9
Lawrence P Guiheen Rev Tr DTD 09/20/19

Director

Non-Executive Director
20,000
20.75
US$415,000 		20,000 20.75 US$415,000
2025-05-21 2025-05-30 PrS Proposed sale
3.9
Guiheen Lawrence P.

Director

Non-Executive Director
20,000
19.44
US$388,800 		20,000 19.44 US$388,800
2025-05-23 2025-05-22 S Sale
3.9
Guiheen Lawrence P.
Non-Executive Director
1,221 -1.1%
20.12
US$24,567 		1,221 -1.1% 20.12 US$24,567
2025-05-23 2025-05-21 S Sale
3.9
Guiheen Lawrence P.
Non-Executive Director
7,779 -6.3%
20.32
US$158,069 		7,779 -6.3% 20.32 US$158,069
2025-05-21 2025-05-21 PrS Proposed sale
3.9
Guiheen Lawrence P.

Director

Non-Executive Director
9,000
20.44
US$183,960 		9,000 20.44 US$183,960
2025-05-16 2025-05-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
19.45
US$116,700 		6,000 -0.3% 19.45 US$116,700
2025-05-16 2025-05-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
19.45
US$291,750 		15,000 -0.7% 19.45 US$291,750
2025-04-16 2025-04-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
21.46
US$128,760 		6,000 -0.3% 21.46 US$128,760
2025-04-16 2025-04-15 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
21.46
US$321,900 		15,000 -0.7% 21.46 US$321,900
2025-03-21 2025-03-19 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
6,000 -0.3%
18.92
US$113,520 		6,000 -0.3% 18.92 US$113,520
2025-03-21 2025-03-19 PlS Planned sale
3.1
Grossman Adam S

President and CEO

Executive Director
15,000 -0.7%
18.92
US$283,800 		15,000 -0.7% 18.92 US$283,800
2025-03-19 2025-03-19 PrS Proposed sale
3.1
Grossman Adam S

Director and Officer

Executive Director
84,000
18.71
US$1,571,640 		84,000 18.71 US$1,571,640
2024-11-22 2024-11-22 PrS Proposed sale
3.1
Grossman Adam S

Director and Officer

Executive Director
48,967
21.30
US$1,042,997 		48,967 21.30 US$1,042,997
2024-11-22 2024-11-22 PrS Proposed sale
3.0
Tade Brad L.

Officer

Officer
15,000
21.30
US$319,500 		15,000 21.30 US$319,500
2024-11-22 2024-11-22 S Sale
3.0
Tade Brad L.

CFO and Treasurer

Officer
15,000 -7.0%
21.15
US$317,250 		15,000 -7.0% 21.15 US$317,250
2024-11-22 2024-11-22 S Sale
3.1
Grossman Adam S

President and CEO

Executive Director
48,967 -2.4%
21.10
US$1,033,204 		48,967 -2.4% 21.10 US$1,033,204
2024-09-11 2024-09-09 S Sale
3.9
Guiheen Lawrence P.
Non-Executive Director
9,000 -5.5%
18.47
US$166,189 		9,000 -5.5% 18.47 US$166,189
2024-09-09 2024-09-09 PrS Proposed sale
3.9
Guiheen Lawrence P.

Director

Non-Executive Director
9,000
16.26
US$146,340 		9,000 16.26 US$146,340
2024-08-30 2024-08-30 PrS Proposed sale
1.7
Kestenberg-Messina Kaitlin M.

Officer

Officer
24,150
17.22
US$415,863 		24,150 17.22 US$415,863
2024-08-30 2024-08-30 S Sale
1.7
Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Officer
24,150 -5.1%
16.90
US$408,050 		24,150 -5.1% 16.90 US$408,050
2024-08-30 2024-08-29 S Sale
3.1
Grossman Jerrold B
Non-Executive Director
136,861 -22.7%
17.27
US$2,363,932 		136,861 -22.7% 17.27 US$2,363,932
2024-08-29 2024-08-29 PrS Proposed sale
3.1
Grossman Jerrold B

Director

Non-Executive Director
136,861
17.24
US$2,359,484 		136,861 17.24 US$2,359,484
2024-08-27 2024-08-27 S Sale
3.1
Grossman Adam S

President and CEO

Executive Director
389,356 -15.9%
17.29
US$6,732,900 		389,356 -15.9% 17.29 US$6,732,900
2024-08-27 2024-08-26 S Sale
3.1
Grossman Adam S

President and CEO

Executive Director
236,889 -10.3%
17.69
US$4,191,088 		236,889 -10.3% 17.69 US$4,191,088
2024-08-26 2024-08-26 PrS Proposed sale
3.1
Grossman Adam S

Officer; Director

Executive Director
626,245
18.20
US$11,397,659 		626,245 18.20 US$11,397,659
2024-08-27 2024-08-23 S Sale
2.6
KWON YOUNG
Non-Executive Director
60,000 -19.9%
18.26
US$1,095,600 		60,000 -19.9% 18.26 US$1,095,600
2024-06-14 2024-06-14 PrS Proposed sale
3.1
Grossman Adam S

Officer; Director

Executive Director
500,000
10.50
US$5,250,000 		500,000 10.50 US$5,250,000
2024-06-14 2024-06-14 S Sale
3.1
Grossman Adam S

President,CEO, and Interim CFO

Executive Director
100,000 -4.6%
10.72
US$1,071,980 		100,000 -4.6% 10.72 US$1,071,980
2024-03-19 2024-03-19 S Sale
2.6
ELMS STEVE
Non-Executive Director
411,829 -16.3%
6.08
US$2,503,920 		411,829 -16.3% 6.08 US$2,503,920
2024-03-19 2024-03-18 S Sale
2.6
ELMS STEVE
Non-Executive Director
49,887 -1.9%
6.01
US$299,821 		49,887 -1.9% 6.01 US$299,821
2024-03-15 2024-03-15 S Sale
2.6
ELMS STEVE
Non-Executive Director
183,008 -6.6%
6.01
US$1,099,878 		183,008 -6.6% 6.01 US$1,099,878
2024-03-15 2024-03-14 S Sale
2.6
ELMS STEVE
Non-Executive Director
448,276 -14.0%
6.05
US$2,712,070 		448,276 -14.0% 6.05 US$2,712,070
2024-03-15 2024-03-13 S Sale
2.6
ELMS STEVE
Non-Executive Director
407,000 -11.3%
6.21
US$2,527,470 		407,000 -11.3% 6.21 US$2,527,470
2024-03-13 2024-03-13 PrS Proposed sale
Aisling Capital II LP

Affiliate
1,500,000
6.22
US$9,330,000 		1,500,000 6.22 US$9,330,000
2023-08-30 2023-08-30 B Purchase
3.1
Grossman Jerrold B
Non-Executive Director
130,000 +41.5%
3.71
US$482,144 		130,000 +41.5% 3.71 US$482,144
2023-08-24 2023-08-24 B Purchase
2.6
KWON YOUNG
Non-Executive Director
25,000 +9.9%
3.90
US$97,500 		25,000 +9.9% 3.90 US$97,500
2023-08-23 2023-08-22 S Sale
1.7
Fong Bryant
Non-Executive Director
1,433,304 -100.0%
3.87
US$5,544,737 		1,433,304 -100.0% 3.87 US$5,544,737
2023-08-22 2023-08-22 PrS Proposed sale
1.7
Bryant Fong

Board Member
1,433,304
3.87
US$5,544,737 		1,433,304 3.87 US$5,544,737
Explore more

More insider trading research around ADMA Biologics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America